Sun Pharma, Dr Reddy's, Glenmark gain even after price-fixing charges in US

Nifty Pharma index, the largest gainer among sectoral indices, was up 2.8%, as compared to unchanged in Nifty 50 index at 10,441 at 09:46 AM

Shares of pharmaceutical companies were in focus and trading higher in otherwise subdued market even after the media reports suggested the four Indian drug makers are facing allegations of a huge price-fixing conspiracy in the US aimed at keeping prices of generic drugs artificially high.

The companies are Dr Reddy’s Laboratories (DRL), Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Emcure, the Business Standard report suggested. CLICK HERE TO READ FULL REPORT

All three listed pharmaceutical companies DRL, Glenmark Pharma and Sun Pharma were up more than 2% each on the National Stock Exchange (NSE). At 09:46 AM;